2026 NPPES data Medical Oncology Physician NPI 1306065446 MD
Verify on CMS →

TAYLOR ORTIZ, MD

Medical Oncology Physician in METHUEN, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
795
Medicare Part D claims · 187 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
72%
generic claims · 28% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

TAYLOR ORTIZ, MD filed 795 Medicare Part D claims in 2023 as a Medical Oncology Physician in METHUEN, Massachusetts, prescribing 72% generic.

795
Part D claims, 2023
72%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

TAYLOR ORTIZ, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

795 Top 29% higher than 71% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

TAYLOR ORTIZ, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about TAYLOR ORTIZ, MD?

Quality data not reported

NPI registry status

Active

Issued 04/25/2007

NPI 1306065446

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

795 15% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Massachusetts

How Medical Oncology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Medical Oncology Physician share within Massachusetts

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Medical Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TAYLOR ORTIZ, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 5 BRANCH ST STE 100, METHUEN, MA, 01844, with a listed phone of (978) 620-2020. NPI 1306065446 was issued on 04/25/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ORTIZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 795 prescription claims written by this provider, covering 187 Medicare beneficiaries and totaling roughly $2.0 million in drug spend, split 28% brand-name and 72% generic by claim count, with an opioid prescribing rate of 4.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5 BRANCH ST STE 100
METHUEN, MA 01844

Provider Details

NPI 1306065446
Specialty Medical Oncology Physician
Credentials MD
Gender Male
NPI Issued 04/25/2007

Hospital and facility affiliations

Facilities where TAYLOR ORTIZ, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

DANA-FARBER CANCER INSTITUTE, INC.
METHUEN, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to TAYLOR ORTIZ, MD. To verify TAYLOR ORTIZ, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

TAYLOR ORTIZ, MD — brand share 28.0%
Specialty average (est.)

28% brand-name claims vs 72% generic, on 795 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

795
Total Claims
$2.0M
Total Drug Cost
187
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,240
Total Day Supply
33,512
Brand vs Generic
28% brand / 72% generic
Brand Drug Cost
$1.8M
Generic Drug Cost
$133K
Opioid Claims
34 (4.3% rate)
Antibiotic Claims
38

Patient Demographics

Average Patient Age
72.4 years
Avg HCC Risk Score
2.48
Gender Split
67% female / 33% male
Age Distribution
<65: 23, 65-74: 91, 75-84: 59, 85+: 14

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What TAYLOR ORTIZ, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
74
Eliquis
Apixaban
47
Gabapentin
38
Dexamethasone
34
Xarelto
Rivaroxaban
33
Imbruvica
Ibrutinib
25
Letrozole
24
Lorazepam
24
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
24
Revlimid
Lenalidomide
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How TAYLOR ORTIZ, MD fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

TAYLOR ORTIZ, MD's 795 claims are above the specialty average of 689.

Nearby Medical Oncology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as ORTIZ.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is TAYLOR ORTIZ, MD's specialty?
TAYLOR ORTIZ, MD specializes in Medical Oncology Physician and practices in METHUEN, Massachusetts. Credentials: MD.
How much does TAYLOR ORTIZ, MD prescribe under Medicare Part D?
In 2023, TAYLOR ORTIZ, MD wrote 795 Medicare Part D claims totaling $2.0M in drug costs for 187 beneficiaries.
Where is TAYLOR ORTIZ, MD located?
TAYLOR ORTIZ, MD is located at 5 BRANCH ST STE 100, METHUEN, MA, 01844. Phone: (978) 620-2020.
What is TAYLOR ORTIZ, MD's NPI number?
TAYLOR ORTIZ, MD's National Provider Identifier (NPI) is 1306065446, issued on 04/25/2007.
Does TAYLOR ORTIZ, MD prescribe more brand-name or generic drugs?
TAYLOR ORTIZ, MD's prescribing is 28% brand-name and 72% generic drugs by claim count, with $1.8M in brand drug costs.
Does TAYLOR ORTIZ, MD prescribe opioids?
Yes, TAYLOR ORTIZ, MD had 34 opioid claims in 2023 with an opioid prescribing rate of 4.3%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does TAYLOR ORTIZ, MD prescribe most often?
Based on 2023 Medicare Part D data, TAYLOR ORTIZ, MD's most frequently prescribed drugs include Anastrozole, Eliquis, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TAYLOR ORTIZ, MD accept Medicare?
TAYLOR ORTIZ, MD appears in CMS Medicare data with 795 Part D claims and 187 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TAYLOR ORTIZ, MD's credentials?
TAYLOR ORTIZ, MD's NPI is 1306065446 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology